Draft:Mark Connors
| Submission declined on 16 May 2024 by HitroMilanese (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 16 May 2024 by Umakant Bhalerao (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources. Declined by Umakant Bhalerao 18 days ago. | |
Comment: Additional references in independent and reliable sources are needed to demonstrate notability. Hitro talk 13:22, 16 May 2024 (UTC)
Mark Connors | |
|---|---|
 | |
| Alma mater | Temple University (BA) Temple University (MD) |
| Known for | Research on Long-term nonprogressors |
| Scientific career | |
| Fields | Immunology |
Mark Connors, M.D., is a prominent researcher at the National Institutes of Health (NIH) specializing in HIV/AIDS. He serves as the chief of the HIV-Specific Immunity Section at the National Institute of Allergy and Infectious Diseases (NIAID), where he oversees efforts to understand and enhance the immune response to HIV. His research focuses on identifying effective immune responses to the virus, which are crucial for developing vaccines and immunotherapies.[1]
Career and Research[edit]
Dr. Connors received his medical degree from Temple University, followed by pediatric training at Tufts Medical Center. He has been with the NIH since 1989, initially studying the immune response to respiratory syncytial virus before shifting his focus to HIV in 1994. His career highlights include pioneering studies on the immunologic control of HIV, particularly in Long-term nonprogressor or "elite controllers" who can manage the virus without antiretroviral therapy. This group of patients has provided valuable insights into potential strategies for HIV treatment and prevention.[1]
One significant achievement in Dr. Connors’ career is the identification of the N6 antibody[2], a potent antibody that can neutralize nearly all HIV strains. This discovery has significant implications for the development of HIV treatments and vaccines, as it targets a crucial part of the virus that attaches to immune cells, making it a promising candidate for therapeutic use.
Dr. Connors' work has not only contributed to our understanding of HIV but also has implications for broader immunological research and public health. His publications and contributions to the scientific community are widely recognized and continue to influence the field of HIV research significantly.
References[edit]
This article incorporates public domain material from websites or documents of the National Institutes of Health.